{"url_path":"/sec/bcab/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1826892/0001193125-26-226631-index.html","accession_number":"0001193125-26-226631","cik":"0001826892","ticker":"BCAB","issuer_name":"BioAtla, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1826892/0001193125-26-226631-index.html","primary_entity_key":"0001826892","primary_entity_name":"BioAtla, Inc."},"word_count":426,"has_tables":true,"body_markdown":"Item 6. Exhibits.\n\nExhibit\n\nNumber\n\nDescription\n\nForm\n\nFile No.\n\nExhibit\n\nExhibit Filing Date\n\nFile/Furnished Herewith\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n1.1\n\n \n\n[Agreement and Plan of Merger, dated as of January 30, 2026, by and between BioAtla, Inc. and Merger Sub.](https://www.sec.gov/Archives/edgar/data/1826892/000119312526031942/bcab-ex1_1.htm)\n\n8-K\n\n001-39787\n\n1.1\n\n01-30-2026\n\n \n\n10.1+*\n\n \n\n[Form of Retention Bonus Agreement between BioAtla, Inc. and certain executive officers](https://www.sec.gov/Archives/edgar/data/1826892/000119312526134499/bcab-ex10_36.htm).\n\n10-K\n\n001-39787\n\n10.36\n\n03-31-2026\n\n \n\n10.2+*\n\n \n\n[Retention Bonus Agreement between BioAtla, Inc. and Jay Short, effective March 20, 2026](https://www.sec.gov/Archives/edgar/data/0001826892/000119312526134499/bcab-ex10_37.htm)\n\n10-K\n\n001-39787\n\n10.37\n\n03-31-2026\n\n \n\n10.3*\n\n \n\n[First Amendment to the License Agreement between BioAtla, Inc. and Context Therapeutics Inc., dated as of May 14, 2026](bcab-ex10_3.htm)\n\n \n\n \n\n \n\n \n\nX\n\n31.1\n\n[Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](bcab-ex31_1.htm)\n\n \n\n \n\n \n\n \n\nX\n\n31.2\n\n[Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](bcab-ex31_2.htm)\n\n \n\n \n\n \n\n \n\nX\n\n32.1†\n\n[Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C.](bcab-ex32_1.htm)\n\n \n\n \n\n \n\n \n\nX\n\n77\n\n \n\n \n\n \n\nSection 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.\n\n \n\n \n\n \n\n \n\n \n\n99.1\n\n \n\n[Amendment No. 1 to Agreement and Plan of Merger, dated as of March 2, 2026, by and between BioAtla, Inc. and BA Merger Sub, Inc.](https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/exh1_1.htm)\n\n8-K\n\n001-39787\n\n1.1\n\n03-02-2026\n\n \n\n101.INS\n\nInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.\n\n \n\n \n\n \n\n \n\nX\n\n \n\n101\n\n \n\nThe following materials from BioAtla’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in iXBRL (inline eXtensible Business Reporting Language): (i) the Condensed Balance Sheets, (ii) the Condensed Statements of Operations and Comprehensive Loss, (iii) the Condensed Statements of Stockholders’ Equity (iv) the Condensed Statements of Cash Flows, and (v) Notes to Condensed Financial Statements, tagged as blocks of text and including detailed tags.\n\n \n\n \n\n \n\n \n\nX\n\n104\n\n \n\nCover Page Interactive Data File (formatted as Inline XBRL document and contained in exhibit 101).\n\n \n\n \n\n \n\n \n\nX\n\n \n\n† Furnished and not filed.\n\n+ Indicates management contract or compensatory plan.\n\n* Portions of this exhibit have been omitted or redacted in accordance with Item 601(a)(5) or Item 601(b)(10)(iv) of Regulation S-K.\n\n78\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\nBioAtla, Inc.\n\nDate: May 15, 2026\n\nBy:\n\n/s/ Jay M. Short, Ph.D.\n\nJay M. Short, Ph.D.\n\nChief Executive Officer\n\n(Principal Executive Officer)\n\n \n\nDate: May 15, 2026\n\nBy:\n\n/s/ Christian Vasquez\n\nChristian Vasquez\n\nChief Financial Officer\n\n(Principal Financial and Accounting Officer)\n\n \n\n79"}